Follow
Prostatype Genomics AB
Nasdaq First North GM (Sweden)
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By giving a comprehensive assessment of the aggressiveness of the prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.
Sector:
HEALTH CARE
IPO
Price
9.65 SEK
Subscription period
17 Sep - 01 Oct 2020
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
PROGEN
SE0014684569
Nasdaq First North GM
Sweden (SE)
Details of share in Prostatype Genomics AB with ticker PROGEN
Status
Inactive
Order book id
Amount of instruments
3 885 320
Par value
Market cap
Currency
SEK
First trading date
27 Oct 2020
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
9.65 SEK
89.8M SEK
17 Sep - 01 Oct 2020
IPO in Prostatype Genomics AB
Type
Ticker
ISIN
Market
OPTION
PROGEN TO1
SE0014956462
Nasdaq First North GM
Sweden (SE)
Details of option in Prostatype Genomics AB with ticker PROGEN TO1
Status
Inactive
Order book id
Amount of instruments
3 885 320
Market cap
Currency
SEK
First trading date
27 Oct 2020
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 10.90 during the subscription period from January 27, 2022 until February 17, 2022.
Type
Price
Pre-money valuation
Time
Files
Exercise
10.90 SEK
27 Jan - 17 Feb 2022
Option exercise terms for PROGEN TO1
People
Fredrik Persson
CEO
Anders Lundberg
Chairman of the board
Michael Häggman
Board member
Karlheinz Schmelig
Board member
Håkan Englund
Board member
Christoph Petry
Board member
Company Details
Sector
HEALTH CARE

Address
Industrivägen 19
Zip code
171 48
City/district
Solna
Country
Sweden (SE)
Registration number
556726-0285
LEI code
549300JO6MPCGPVHVU91
First trade date
27 Oct 2020
Registration date
12 Mar 2007
Short name
Prostatype Genomics

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date